INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio update as at 30 June 2010
Total Net Assets |
£96.6m |
NAV per share |
160.0p |
Share Price |
141.5p |
Total value of unquoted investments |
£23.1m |
Total number of portfolio companies |
60 |
Cash |
3% |
Cash committed and reserved to unquoted investments |
14% |
Portfolio companies with < 1 year of cash |
7% |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
5.77 |
Amgen |
5.67 |
Micromet |
5.39 |
Shire |
4.86 |
Alexion Pharmaceuticals |
4.06 |
Genzyme |
3.65 |
Gilead Sciences |
3.54 |
EV3 |
3.45 |
EUSA Pharma |
3.24 |
Oxagen |
3.01 |
|
----------- |
Total |
42.64 |
Geographical Allocation |
% |
United States |
75 |
Europe |
20 |
Cash |
3 |
Australia |
2 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
73 |
Unquoted |
24 |
Cash |
3 |
|
----------- |
|
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 JULY 2010